BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Prognosis
29 results:

  • 1. Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201).
    Imai H; Sakamoto Y; Takahashi S; Shibata H; Sato A; Otsuka K; Amagai K; Takahashi M; Yamaguchi T; Ishioka C
    BMC Cancer; 2024 Feb; 24(1):262. PubMed ID: 38402399
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Lung carcinoid tumours: histology and Ki-67, the eternal rivalry.
    Centonze G; Maisonneuve P; Simbolo M; Lagano V; Grillo F; Fabbri A; Prinzi N; Garzone G; Filugelli M; Pardo C; Mietta A; Pusceddu S; Sabella G; Bercich L; Mangogna A; Rolli L; Grisanti S; Benvenuti MR; Pastorino U; Roz L; Scarpa A; Berruti A; Capella C; Milione M
    Histopathology; 2023 Jan; 82(2):324-339. PubMed ID: 36239545
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
    Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
    [No Abstract]    [Full Text] [Related]  

  • 4. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
    Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
    [No Abstract]    [Full Text] [Related]  

  • 5. Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies.
    Beaufrère A; Caruso S; Calderaro J; Poté N; Bijot JC; Couchy G; Cauchy F; Vilgrain V; Zucman-Rossi J; Paradis V
    J Hepatol; 2022 Feb; 76(2):343-352. PubMed ID: 34624411
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Extent of Lymph Node Dissection for Accurate Staging in Intrahepatic Cholangiocarcinoma.
    Kim SH; Han DH; Choi GH; Choi JS; Kim KS
    J Gastrointest Surg; 2022 Jan; 26(1):70-76. PubMed ID: 34100250
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical characteristics and treatment analysis of pancreatic acinar cell carcinoma: A single institutional comparison to pancreatic ductal adenocarcinoma.
    Huang X; Li M; Zhang L; Xiong J; Lu H; Tian B
    Surg Oncol; 2021 Jun; 37():101528. PubMed ID: 33611029
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genome-wide analysis identifies critical DNA methylations within NTRKs genes in colorectal cancer.
    Chen Z; Huang Z; Luo Y; Zou Q; Bai L; Tang G; Wang X; Cao G; Huang M; Xiang J; Yu H
    J Transl Med; 2021 Feb; 19(1):73. PubMed ID: 33593392
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Pathological characteristics and survival analysis of 355 patients with gastroenteropancreatic neuroendocrine neoplasms].
    Li Y; Wang YF; Tan BB; Er LM; Zhao Q; Fan LQ; Zhang ZD; Liu Y
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):426-431. PubMed ID: 32482035
    [No Abstract]    [Full Text] [Related]  

  • 10. Prognostic and predicted significance of Ubqln2 in patients with hepatocellular carcinoma.
    Luo YD; Yu HQ; Liu XY; Huang D; Dai HS; Fang L; Zhang YJ; Lai JJ; Jiang Y; Shuai L; Zhang LD; Chen G; Bie P; Xie CM
    Cancer Med; 2020 Jun; 9(12):4083-4094. PubMed ID: 32293796
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinicopathological features and prognosis of 488 patients with neuroendocrine tumors].
    Zhai XJ; Yu SL; Ma YH; Wang F; Yang MJ; Lian YJ; Yu XX; Fan QX; Song LJ
    Zhonghua Yi Xue Za Zhi; 2019 Aug; 99(32):2527-2531. PubMed ID: 31484281
    [No Abstract]    [Full Text] [Related]  

  • 12. Cystic pancreatic neuroendocrine tumors: A distinctive subgroup with indolent biological behavior? A systematic review and meta-analysis.
    Zhu JK; Wu D; Xu JW; Huang X; Jiang YY; Edil BH; Li M; Hu SY; Zhan HX
    Pancreatology; 2019 Jul; 19(5):738-750. PubMed ID: 31160191
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The expression of death receptor systems TRAIL-R1/-R2/-R4, cd95 and TNF-R1 and their cognate ligands in pancreatic ductal adenocarcinoma.
    Gaertner F; Krüger S; Röder C; Trauzold A; Röcken C; Kalthoff H
    Histol Histopathol; 2019 May; 34(5):491-501. PubMed ID: 30375637
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pathological Significance and Prognostic Value of Surfactant Protein D in cancer.
    Mangogna A; Belmonte B; Agostinis C; Ricci G; Gulino A; Ferrara I; Zanconati F; Tripodo C; Romano F; Kishore U; Bulla R
    Front Immunol; 2018; 9():1748. PubMed ID: 30127783
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Expression and prognostic value of c-Myc and fas (cd95/APO1) in patients with pancreatic cancer.
    He C; Jiang H; Geng S; Sheng H; Shen X; Zhang X; Zhu S; Chen X; Yang C; Gao H
    Int J Clin Exp Pathol; 2014; 7(2):742-50. PubMed ID: 24551298
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis.
    Han L; Chen W; Zhao Q
    Tumour Biol; 2014 Mar; 35(3):2473-80. PubMed ID: 24218336
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells.
    Moniri MR; Sun XY; Rayat J; Dai D; Ao Z; He Z; Verchere CB; Dai LJ; Warnock GL
    Cancer Gene Ther; 2012 Sep; 19(9):652-8. PubMed ID: 22767216
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. PPARγ potentiates anticancer effects of gemcitabine on human pancreatic cancer cells.
    Koga H; Selvendiran K; Sivakumar R; Yoshida T; Torimura T; Ueno T; Sata M
    Int J Oncol; 2012 Mar; 40(3):679-85. PubMed ID: 22020928
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Influence of obesity and other risk factors on survival outcomes in patients undergoing pancreaticoduodenectomy for pancreatic cancer.
    Dandona M; Linehan D; Hawkins W; Strasberg S; Gao F; Wang-Gillam A
    Pancreas; 2011 Aug; 40(6):931-7. PubMed ID: 21747317
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Calmodulin mediates fas-induced FADD-independent survival signaling in pancreatic cancer cells via activation of Src-extracellular signal-regulated kinase (ERK).
    Yuan K; Jing G; Chen J; Liu H; Zhang K; Li Y; Wu H; McDonald JM; Chen Y
    J Biol Chem; 2011 Jul; 286(28):24776-84. PubMed ID: 21613217
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.